Caas Capital Management LP Novo Cure LTD Transaction History
Caas Capital Management LP
- $1.31 Billion
- Q1 2024
A detailed history of Caas Capital Management LP transactions in Novo Cure LTD stock. As of the latest transaction made, Caas Capital Management LP holds 2,300 shares of NVCR stock, worth $38,640. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,300Holding current value
$38,640% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding NVCR
# of Institutions
277Shares Held
73.2MCall Options Held
1.43MPut Options Held
832K-
Vanguard Group Inc Valley Forge, PA10MShares$168 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.08MShares$153 Million0.0% of portfolio
-
Capital International Investors Los Angeles, CA8.86MShares$149 Million0.03% of portfolio
-
State Street Corp Boston, MA3.36MShares$56.5 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.38MShares$40 Million0.0% of portfolio
About NovoCure Ltd
- Ticker NVCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 104,950,000
- Market Cap $1.76B
- Description
- NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...